A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad
Submitted: May 21, 2020
Accepted: June 23, 2020
Published: August 6, 2020
Accepted: June 23, 2020
Abstract Views: 918
PDF: 669
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.